the global flow cytometry market is categorized into cell-based and bead-based flow cytometry. The bead-based technology segment is expected to grow at the highest CAGR during the forecast period, owing to the procedural advantages offered by this technology over other cell-based technology (enzyme-linked immunosorbent assay (ELISA) and western blot), such as the capacity to detect multiple analytes (also known as multiplexing), high reproducibility, stability, and speed. Еще
